Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Mahmoud Hadipour Dehshal, Mehdi Tabrizi Namini, Alireza Ahmadvand, Mohsen Manshadi, Forouzan Sadeghian Varnosfaderani & Hassan Abolghasemi. (2014) Evaluation of the National Prevention Program in Iran, 2007–2009: the Accomplishments and Challenges with Reflections on the Path Ahead. Hemoglobin 38:3, pages 179-187.
Read now
Read now
Mahmoud Hadipour Dehshal, Alireza Ahmadvand, Sakineh Yousefi Darestani, Mohsen Manshadi & Hassan Abolghasemi. (2013) Secular Trends in the National and Provincial Births of New Thalassemia Cases in Iran From 2001 to 2006. Hemoglobin 37:2, pages 124-137.
Read now
Read now
Ebrahim Miri-Moghaddam, Azita Zadeh-Vakili, Abbas Nikravesh, Shohreh Sanei Sistani & Mehrnaz Naroie-Nejad. (2013) Sistani Population: a Different Spectrum oF β-Thalassemia Mutations From other Ethnic Groups of Iran. Hemoglobin 37:2, pages 138-147.
Read now
Read now
Ebrahim Miri-Moghaddam & Azita Zadeh-Vakili. (2012) Profile of β-Thalassemia and its Prenatal Diagnosis in Khorasan-E-Jonobi Province, Iran. Hemoglobin 36:5, pages 456-463.
Read now
Read now
Mohammad Saeid Rahiminejad, Sirous Zeinali, Abdolreza Afrasiabi & Ali Kord Valeshabad. (2011) β-Thalassemia Mutations Found During 1 Year of Prenatal Diagnoses in Fars Province, Iran. Hemoglobin 35:4, pages 331-337.
Read now
Read now
Amal El-Beshlawy & Ilham Youssry. (2009) Prevention of Hemoglobinopathies in Egypt. Hemoglobin 33:sup1, pages S14-S20.
Read now
Read now
Articles from other publishers (6)
Jafar Hassanzadeh, Alireza Mirahmadizadeh, Mehran Karimi & Shahab Rezaeian. (2016) Delay in Diagnosis of Hemoglobulinopathies (Thalassemia, Sickle Cell Anemia): A Need for Management of Thalassemia Programs. Iranian Journal of Pediatrics 27:2.
Crossref
Crossref
Nejat Mahdieh & Bahareh Rabbani. (2016) Beta thalassemia in 31,734 cases with HBB gene mutations: Pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East. Blood Reviews 30:6, pages 493-508.
Crossref
Crossref
Theera Tongsong, Pimlak Charoenkwan, Pannee Sirivatanapa, Chanane Wanapirak, Wirawit Piyamongkol, Supatra Sirichotiyakul, Kasemsri Srisupundit, Fuanglada Tongprasert, Suchaya Luewan, Thawalwong Ratanasiri, Ratana Komwilaisak, Piyamas Saksiriwuttho, Chutawadi Vuthiwong, Peerapun Punpuckdeekoon, Prisana Panichkul, Wibool Rueangchainikhom, Jirawat Choowong, Nawaporn Orungrote, Sravuth Sarapak, Ekachai Kovavisarach, Prapon Jaruyawongs, Thitinan Tansathit, Podjanee Phadungkiatwattana, Jittima Rujiwetpongstorn, Ounjai Kor‐anantakul, Chitkasaem Suwanrath, Tharangrut Hanprasertpong & Savitree Pranpanus. (2013) Effectiveness of the model for prenatal control of severe thalassemia. Prenatal Diagnosis 33:5, pages 477-483.
Crossref
Crossref
Zohreh Rahimi. (2013) Genetic Epidemiology, Hematological and Clinical Features of Hemoglobinopathies in Iran. BioMed Research International 2013, pages 1-10.
Crossref
Crossref
E. Miri‐Moghaddam, A. Zadeh‐Vakili, Z. Rouhani, M. Naderi, P. Eshghi & A. Khazaei Feizabad. (2011) Molecular basis and prenatal diagnosis of β‐thalassemia among Balouch population in Iran. Prenatal Diagnosis 31:8, pages 788-791.
Crossref
Crossref
Piero C. Giordano. (2009) Prospective and retrospective primary prevention of Hemoglobinopathies in multiethnic societies. Clinical Biochemistry 42:18, pages 1757-1766.
Crossref
Crossref